The Genetic Code and Gene Regulation: How Cells Read, Control and Use DNA
Core idea The genetic code is the rule that maps nucleotide triplets in mRNA to amino acids. Gene regulation determines which genes are transcribed, in which cells, at what time and at what level. The same genome can therefore produce neurons, hepatocytes and lymphocytes with different functions. Learning outcomes Use codons and reading frames correctly; explain initiation, elongation and termination; describe promoter, enhancer, silencer and epigenetic control; compare prokaryotic operons with eukaryotic regulation; and connect regulatory failure to disease, cancer and treatment. 1. The genetic code Messenger RNA is read in groups of three nucleotides called codons. There are 64 codons: 61 specify amino acids and three are stop codons. AUG usually serves as the start codon and specifies methionine. The code is redundant because several codons can specify one amino acid, but it is not ambiguous: each codon has one meaning in a given code. The code is nearly universal, with important mitochondrial variations. A reading frame is established by the start site and must be maintained; insertion or deletion of a number of bases not divisible by three causes a frameshift and changes all downstream codons. Mutation effect Meaning Likely consequence Synonymous Codon changes but amino acid remains the same. Often mild, but may affect splicing, mRNA stability or translation speed. Missense One amino acid is replaced. Effect depends on residue, domain, conservation and protein function. Nonsense Codon becomes a premature stop. Truncated protein or nonsense-mediated mRNA decay. Frameshift Insertion/deletion alters triplet grouping. Abnormal downstream sequence and often premature termination. Splice-altering Changes exon–intron processing. Exon skipping, intron retention or abnormal transcript. 2. Translation Initiation assembles the ribosome at the start codon; elongation cycles through codon recognition, peptide-bond formation and translocation; termination occurs when a stop codon recruits release factors. Transfer RNA anticodons pair with mRNA codons and deliver amino acids. Ribosomes may attach to the rough endoplasmic reticulum when the nascent protein has a signal peptide. Translation is regulated by nutrient status, stress responses, microRNAs and initiation-factor phosphorylation. A transcript can be present but poorly translated, so RNA abundance alone does not always predict protein abundance or clinical effect. 3. Promoters and transcription initiation A promoter contains DNA elements where general transcription factors and RNA polymerase assemble. Core promoter motifs vary by gene. Cell-specific transcription factors bind nearby regulatory sequences and recruit co-activators, chromatin remodelers or co-repressors. A promoter variant may reduce transcription without changing the coding sequence. 4. Enhancers, silencers and insulators Enhancers can act thousands of bases away and often work through DNA looping to contact a promoter. Silencers reduce transcription through repressor proteins and chromatin compaction. Insulators and boundary elements prevent an enhancer from activating the wrong neighbouring gene. Structural variants can move an enhancer next to a different gene and cause disease through “enhancer hijacking.” 5. Epigenetic regulation DNA methylation at many promoter CpG sites is associated with reduced transcription, although context matters. Histone acetylation usually opens chromatin, while selected histone methylation marks can activate or repress. Nucleosome positioning controls access for polymerases and transcription factors. Epigenetic states are heritable through cell division but can be altered by development, inflammation, nutrition and drugs. 6. Regulation after transcription Alternative splicing creates different mRNAs from one gene. RNA editing changes selected bases; poly-A length affects stability; RNA-binding proteins control transport and degradation; and microRNAs guide repression or transcript destruction. These layers allow rapid adaptation and tissue-specific expression. 7. Prokaryotic operons In bacteria, related genes may be transcribed as one polycistronic mRNA. The lac operon is induced when lactose is available and glucose is low: the repressor is removed by allolactose and CAP–cAMP helps recruit polymerase. The trp operon is repressed when tryptophan is abundant and can use attenuation to sense translation. Operons provide efficient metabolic control. 8. Eukaryotic gene control Eukaryotes separate transcription in the nucleus from translation in the cytoplasm and use chromatin, enhancers, promoter choice, RNA processing, transport, translation and protein degradation. A signal such as a steroid hormone can bind an intracellular receptor that acts as a transcription factor. Growth-factor receptors activate kinase cascades that ultimately modify nuclear transcription factors. 9. Cell signalling and gene regulation Ligand binding to a receptor can activate second messengers, protein kinases and transcription factors. The MAPK pathway often supports proliferation; JAK–STAT transmits cytokine signals; NF-kB responds to inflammation; and TGF-beta regulates differentiation and extracellular matrix. Mutations that activate signalling independently of a ligand can produce cancer or developmental disease. 10. Regulation in development and differentiation Cells remember their identity through stable combinations of transcription factors and epigenetic marks. Master regulators activate networks rather than single traits. During development, a transient signal can establish a self-reinforcing programme; later, chromatin changes maintain the state. Errors can cause congenital malformations, failed differentiation or malignancy. 11. When regulation goes wrong Promoter silencing Methylation can reduce expression of a tumour suppressor or produce imprinting-related disease. Enhancer disruption Deletion or translocation can separate a gene from its normal regulatory landscape. Splicing failure Variants or altered splicing factors generate abnormal transcripts and proteins. Abnormal signalling Constitutive kinase or transcription-factor activity drives proliferation, inflammation or fibrosis. 12. Clinical interpretation When a variant lies outside a coding exon, ask whether it could affect promoter, enhancer, splice, untranslated-region or chromatin function. RNA studies can demonstrate aberrant splicing; methylation assays can assess imprinting or epigenetic silencing; chromatin and expression studies may support regulatory mechanisms. The absence of a coding mutation does not exclude a regulatory disorder. Do not assume “non-coding” means “non-functional.” Regulatory DNA, untranslated regions and non-coding RNAs can be essential to the timing, tissue specificity and amount of gene expression. 13. Examination summary The genetic code determines how mRNA triplets specify protein, while gene regulation decides when and where that code is used. Promoters initiate transcription; enhancers and silencers tune it; chromatin and epigenetic marks control access; RNA processing and degradation adjust transcripts; translation and protein turnover complete the control system. Disease can result from coding variants, regulatory disruption, abnormal splicing or pathway misactivation. References SlideShare: Genetic Code. SlideShare: Gene Regulation. OpenStax: Regulation of Gene
